Smallpox B (Mpox)

Smallpox B (Mpox), formerly known as monkeypox, is a rare viral infectious disease caused by the monkeypox virus and transmitted primarily from rodents to humans, and then from person to person, mainly through contact with skin lesions.

Our missions

  • Epidemiological surveillance and case investigation, particularly of clusters

  • Contributing to research efforts to advance scientific knowledge at the national and international levels

  • Participation in expert assessments of vaccination and care policies

  • Vaccine logistics (procurement, inventory management, and distribution)

  • Development and distribution of tools, and implementation of information and prevention campaigns targeting at-risk populations

vaccination-info-service.fr - Le site de référence qui répond à vos questions

Data

Cases of Smallpox B (Mpox) Detected in France

From January 1 to June 30, 2026, 267 cases of smallpox B (mpox) were reported, including 10 without laboratory confirmation (Figure 1). The number of cases reported in the second quarter of 2026 (April–June) was three times that of the first quarter (January–March).

Learn more

bulletin national

29 May 2026

Smallpox B (mpox) in France from January 1 to June 30, 2026

Read the newsletter

Situation in Europe and Around the World

The second Public Health Emergency of International Concern (PHEIC) related to smallpox B (Mpox), declared by the World Health Organization (WHO) in August 2024, was lifted in September 2025. In Africa, a decline in the number of cases has been observed since September 2025. In October 2025, the ECDC assessed the risk of infection with clade Ib as moderate among men who have sex with men living in Europe and low for the general population. 

See also: